Sebacia

Duluth, United States Founded: 2010 • Age: 16 yrs
Develops topical microparticle therapies for dermatological conditions.
Annual revenue - Latest available
Total funding $72.7M 10 rounds
Employees 14 Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Sebacia

Sebacia is a company based in Duluth (United States) founded in 2010. It operates as a B2B. Sebacia has raised $72.73 million across 10 funding rounds from investors including Hercules Capital, Square 1 Bank and Salem Partners. The company has 14 employees as of December 31, 2019. Sebacia operates in a competitive market with competitors including Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.

  • Headquarter Duluth, United States
  • Employees 14 as on 31 Dec, 2019
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sebacia, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $72.73 M (USD)

    in 10 rounds

  • Latest Funding Round
    $10 M (USD), Series D

    Sep 13, 2019

  • Investors
  • Employee Count
    14

    as on Dec 31, 2019

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sebacia

Sebacia has successfully raised a total of $72.73M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series D — $10.0M
  • First Round

    (11 Jun 2010)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2019 Amount Series D - Sebacia Valuation

investors

Jul, 2017 Amount Series D - Sebacia Valuation Versant Ventures
Jul, 2017 Amount Debt – Venture - Sebacia Valuation

investors

Investors in Sebacia

Sebacia has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hercules Capital, Square 1 Bank and Salem Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
Founded Year Domain Location
Life science & tech focused VC firm investing in the US
Founded Year Domain Location
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
Founded Year Domain Location

Investments & Acquisitions by Sebacia

Investments

Financial Statements - Sebacia

Sebacia Comparisons

+
Add Comparison
Available on Premium

Competitors of Sebacia

Sebacia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-invasive energy device for hyperhidrosis treatment is provided.
domain founded_year HQ Location
Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections
domain founded_year HQ Location
Offers coal tar and light combination therapy for effective psoriasis treatment.
domain founded_year HQ Location
Nanoparticle-based products for cosmetics and health sectors are developed.
domain founded_year HQ Location
Sells devices for fat reduction, body shaping, and skin firming online.

Frequently Asked Questions about Sebacia

Sebacia was founded in 2010.

Sebacia is headquartered in Duluth, United States.

Sebacia is a funded company, having raised a total of $72.73M across 10 funding rounds to date. The company's 1st funding round was a Debt – Venture of $16M, raised on Jun 11, 2010.

As of Dec 31, 2019, the latest employee count at Sebacia is 14.

Sebacia develops topical microparticle therapies for dermatological conditions through providing healthcare solutions, producing pharmaceutical products, dermatology, and topical therapies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Sebacia's top competitors include Candesant, PhotoSonix Medical and Nano Ceuticals.

Sebacia has 7 investors. Key investors include Hercules Capital, Square 1 Bank, Salem Partners, Versant Ventures, and Domain Associates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available